Nukkleus Inc. (NASDAQ:NUKK) experienced a 4.1% uptick in premarket trading following an announcement that its wholly owned subsidiary, B. Rimon Agencies Inc., has been awarded several multi-year contracts to produce components for Israeli national missile defense systems.
According to the company, Rimon has entered into agreements with multiple leading Israeli defense original equipment manufacturers to manufacture critical parts used in the Iron Dome anti-missile defense system as well as other national security platforms. The aggregate value of these newly awarded contracts is approximately $4.1 million, which the company says will supplement Rimon's existing revenue projections.
The contracts are structured to provide predictable, long-term revenue streams tied to active defense programs. Nukkleus emphasized that the work will support ongoing operational needs within those programs, adding continuity to Rimon's forecasted cash flows from its defense-related operations.
Company background and capabilities
Founded in 1988, B. Rimon Agencies Inc. designs and delivers customized field-ready platforms that integrate power generation, communications, sensor infrastructure, and mobility solutions. The company has served as a partner on long-term defense programs for decades and positions its products as turnkey subsystems for complex operational requirements.
"These agreements highlight the importance of the execution layer in modern defense programs," said Menny Shalom, Chief Executive Officer of Nukkleus. "Systems like the Iron Dome rely not only on prime contractors, but on a network of highly specialized suppliers, capable of delivering critical subsystems reliably and at scale."
Strategic alignment
Nukkleus framed the awards as consistent with its strategy of building a collection of defense businesses that operate at structurally constrained points of the industrial base. The company described its operating approach as one that combines decentralized execution with centralized capital allocation and strategic oversight.
Market reaction
Investors reacted to the announcement with a modest premarket boost to Nukkleus shares. The company indicated the contracts will add to Rimon's projected revenues and create longer-dated, program-linked revenue visibility for that subsidiary.
Limitations
The company statement focuses on the contracts' value and strategic fit but does not provide a detailed revenue schedule, margin expectations, or timing for deliveries tied to the awards. Additional disclosure would be required to assess near-term cash flow impacts or margin contributions from the work.